EMPLOYMENT AGREEMENTEmployment Agreement • February 25th, 2020 • Intercept Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 25th, 2020 Company Industry JurisdictionTHIS EMPLOYMENT AGREEMENT (this “Agreement”), made effective as of November 19, 2019, is entered into by Intercept Pharmaceuticals, Inc. (the “Company”) and Jason Campagna (“Executive”).
October 25, 2019 Via Facsimile (with copy by email) Mark Pruzanski, M.D. President and Chief Executive Officer Intercept Pharmaceuticals, Inc. Fax: +1-646-747-1001 Re: Termination of License Agreement Dear Dr. Pruzanski:License Agreement • February 25th, 2020 • Intercept Pharmaceuticals, Inc. • Pharmaceutical preparations
Contract Type FiledFebruary 25th, 2020 Company IndustryReference is made to that certain LICENSE AGREEMENT between Intercept Pharmaceuticals, Inc. (“Intercept”) and Sumitomo Dainippon Pharma Co., Ltd. (“Sumitomo”) dated as of March 29th, 2011 regarding INT-747, as amended (the “License Agreement”).